Bioavailable copper levels can be decreased in vivo by copper chelating agents. by Andrew Crowe (450839)

Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)

Bcl6 deficiency decreases expression of lipogenic genes and proteins in liver. by Christopher R. LaPensee (571785)

NTCU-induced increase in K5 and K14 expressing basal cells and decrease in CCSP and ACT positive cells in the tracheal epithelium. by Moumita Ghosh (344206)

DICER protein expression is significantly decreased in the absence of MOV10 and FMRP. by Monica C. Lannom (11772729)

rHSP60 decreases LPS-induced mononuclear cell proliferation. by Igor Emiliano L. Souza (18196495)

Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced degranulation. by Jian Hao (160736)

RV-decreases IRAK-1 protein via TLR2 activation. by Benjamin L. Unger (130418)

Oligospermia and decreased fertility in <i>Chtf18</i>-null mice. by Karen M. Berkowitz (123502)

TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

Placental aromatase expression decreased in severe neonatal opioid withdrawal syndrome by Courtney Townsel (6705368)

MMP7 expression decreases upon inhibition of PRL3 activity. by Srikanta Basu (721886)

The p.I126S mutation decreases FOXC1 DNA-binding. by Cristina Medina-Trillo (705087)

Transduction of Gsx2 decreases the capacity of OBSCs to differentiate into astrocytes and oligodendrocytes. by Héctor R. Méndez-Gómez (189198)

IFN-λ decreases miR-122 transcription in HCV cells. by Fatma Aboulnasr (736868)

Inactivation of the spermidine transporter led to decreased transcription of T3SS genes. by Lian Zhou (272766)

Downregulation of CHOP decreases apoptosis by activation of ER stress-induced autophagy. by Yan Lei (535846)

Decreased cellular infiltration into lungs of <i>Ifi35</i> deficient mice after H5N1-VN/PR8 infection. by Anshu P. Gounder (626041)

Proliferation marker Ki-67 is decreased by rLOX-PP treatment. by Manish V. Bais (333481)

Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2. by Shaija Samuel (341436)

“…NRP-2-siRNA DOPC-treatment led to a significant decrease in tumor growth compared with cntr siRNA DOPC-treatment (264.4 mm³ vs. 751.3 mm³, respectively; *<i>p</i> = 0.01). …”